Stoke Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 03/08/2026 | Mar 2026Filed 03/08/2026 | Sep 2025Filed 04/11/2025 | Jun 2025Filed 03/08/2026 | Mar 2025Filed 03/08/2026 | Sep 2024Filed 04/11/2025 | Jun 2024Filed 04/11/2025 | Mar 2024Filed 04/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $9.3 | $6.2 | $11 | $14 | $159 | $4.9 | $4.8 | $4.2 | |
| −$62 | −$50 | −$38 | −$23 | $113 | −$26 | −$26 | −$26 | |
| −$0.93 | −$0.79 | −$0.65 | −$0.40 | $1.90 | −$0.47 | −$0.46 | −$0.57 | |
| 66 | 63 | 59 | 58 | 59 | 56 | 56 | 46 |
Trend